Cargando…
Tumor Cell Invasion in Glioblastoma
Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16 months. Recent research has revealed novel insights into the outstanding heterogeneity of this type of brain cancer. However, all GBM subtypes share the hallmark feature of aggressive invasion into the surround...
Autores principales: | Vollmann-Zwerenz, Arabel, Leidgens, Verena, Feliciello, Giancarlo, Klein, Christoph A., Hau, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139341/ https://www.ncbi.nlm.nih.gov/pubmed/32178267 http://dx.doi.org/10.3390/ijms21061932 |
Ejemplares similares
-
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
por: Leidgens, Verena, et al.
Publicado: (2016) -
Neutrophils Promote Glioblastoma Tumor Cell Migration after Biopsy
por: Chen, Na, et al.
Publicado: (2022) -
Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms
por: Leidgens, Verena, et al.
Publicado: (2015) -
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
por: Ammer, Laura-Marie, et al.
Publicado: (2020) -
Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells
por: Seliger, Corinna, et al.
Publicado: (2023)